Viewing nowPregabalin Capsules 300 mg (Pregabalin)
Pregabalin 300mg
Hard capsule · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 202002582 · Approved 2020.04.13 · Insurance code 650304030
Treatment of neuropathic pain, adjunctive treatment of partial-onset seizures, treatment of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. It is also used as an adjunct for partial seizures in patients with epilepsy, whether or not accompanied by secondary generalized symptoms. Additionally, it is effective in alleviating the symptoms of fibromyalgia. This medication is widely used for various neurological disorders and pain management.
Administer the total daily dose of this medicine, which contains pregabalin, orally in 2 divided doses, with or without food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section '5. Patients with renal impairment') 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose of this medicine may be 150mg daily. Based on each patient's response and tolerability, the dose may be increased to 300mg daily after 3 to 7 days. If necessary, the dose may subsequently be increased at 7-day intervals to a maximum of 600mg daily. 2) Central neuropathic pain Adults: The initial dose of this medicine may be 150mg daily. Based on each patient's response and tolerability, the dose may be increased to 300mg daily after 1 week. After an additional week, the dose may be increased to the target daily dose of 600mg. If the target daily dose is not tolerated, dose reduction may be considered. (See section '4. Discontinuation of treatment') 2. Epilepsy Adults: The initial dose of this medicine may be 150mg daily. Based on each patient's response and tolerability, the dose may be increased to 300mg daily after 1 week. If necessary, the dose may subsequently be increased at 7-day intervals to a maximum of 600mg daily. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300mg~450mg daily. The initial dose is 75mg twice daily (150mg daily); based on efficacy and tolerability, it may be increased within 1 week to 150mg twice daily (300mg daily). For patients who do not experience sufficient benefit at a dose of 300mg daily, the dose may be increased within 1 week to 225mg twice daily (450mg daily). Although clinical studies have also been conducted at a dose of 600mg daily, there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450mg daily are not recommended. 4. Discontinuation of treatment Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys as unchanged drug. The clearance of this medicine is directly affected by creatinine clearance; therefore, dose reductions in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the formula below. For women, multiply the result obtained from the above calculation by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, a supplemental dose should be administered promptly after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosage based on renal function ≥60: Starting dose 150 mg/day, maximum dose 600 mg/day, BID or TID ≥30-<60: Starting dose 75 mg/day, maximum dose 300 mg/day, BID or TID ≥15-<30: Starting dose 25-50 mg/day, maximum dose 150 mg/day, QD or BID <15: Starting dose 25 mg/day, maximum dose 75 mg/day, QD Supplemental dose after hemodialysis: Starting dose 25 mg, maximum dose 100 mg, single dose b TID = total daily dose administered in 3 divided doses BID = total daily dose administered in 2 divided doses QD = administered once daily a: The total daily dose (mg/day) should be divided as specified in the administration instructions. b: Supplemental dose refers to a dose administered as a single additional dose. 6. Patients with hepatic impairment No dose adjustment is necessary in patients with hepatic impairment. 8. Older adults (aged 65 years and older) Dose reduction may be necessary in older adults with impaired renal function.
Children younger than 12 years: Use is not recommended because there are insufficient data on safety and efficacy. Adolescents aged 12 to 17 years: Use is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behavior, so if any signs of depression or mood changes occur during treatment, it should be reported to a healthcare professional immediately. Patients who are allergic to any component of this medication or have certain hereditary lactose intolerance should not take it. Diabetic patients may need to adjust their dosage of blood glucose control medication due to weight gain. If symptoms of angioedema occur, the medication should be stopped immediately, and caution is necessary for the elderly due to the risk of accidents from dizziness or drowsiness. Blurred vision or changes in eyesight may occur, and if these symptoms arise, consultation with a healthcare professional is advisable. Sudden discontinuation of this medication may result in withdrawal symptoms such as insomnia, headache, and anxiety, so it should be tapered off gradually according to a healthcare professional's instructions. Patients with a history of substance abuse are at higher risk of misuse with this medication, requiring caution during administration. Patients with impaired renal function may require dosage adjustments. Patients with heart disease should use this medication with caution, and concurrent use with opioid analgesics may increase the risk of central nervous system depression. In early pregnancy, this medication may affect the fetus, so women who are pregnant or planning to become pregnant should consult a healthcare professional and use effective contraception. Breastfeeding women should consult a healthcare professional before taking this medication as it can be transferred to breast milk and affect the infant. Activities requiring concentration, such as driving or operating machinery, should be avoided until dizziness or drowsiness has resolved after taking this medication. In the case of overdose, symptoms such as confusion, drowsiness, seizures, etc., may occur, so the dosage should be adhered to, and if any abnormal symptoms arise, a healthcare facility should be contacted immediately. Keep out of reach of children and ensure it is not transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, preferably in a cool place between 15 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness for a longer period.
A hard capsule with a reddish-brown upper part and a white lower part containing a white powder that is white or light yellow.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 300mg
Hard capsule · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.